Robert Huang, MD
Otolaryngology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Huang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A62150 · Current
Licensed to practise in California · since 1997 · expires 2028-09-30 · Northwestern University Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$177,450
Medicare paid this office $177,450 for 589 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 322 | $50,753 | $111 |
| Diagnostic exam of voice box using a flexible endoscope | 245 | $41,642 | $128 |
| New patient visit (45+ min) | 244 | $32,021 | $131 |
| Removal of impacted ear wax | 241 | $11,096 | $39 |
| Long return visit (40+ min) | 51 | $8,806 | $163 |
See all 8 services
| Return visit (30+ min) | 322 | $50,753 | $111 |
| Diagnostic exam of voice box using a flexible endoscope | 245 | $41,642 | $128 |
| New patient visit (45+ min) | 244 | $32,021 | $131 |
| Removal of impacted ear wax | 241 | $11,096 | $39 |
| Long return visit (40+ min) | 51 | $8,806 | $163 |
| Short return visit (20+ min) | 43 | $3,871 | $76 |
| Simple control of nose bleed | 18 | $3,775 | $157 |
| New patient visit (60+ min) | 17 | $3,366 | $198 |
Who their Medicare patients are
589 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 21% · Women 56% · Also on Medicaid 15% · Health risk score 0.98. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 64% · Diabetes 23% · Coronary heart disease 22% · Chronic kidney disease 19% · Cancer 17% · Atrial fibrillation 16% · Depression 14% · Heart failure 10% · COPD 9% · Stroke 6% · Dementia 5%.
The office billed $693,432, Medicare allowed $243,251 and paid $177,450; for 1,579 services of 45 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 589 | 1,579 | 77 | 0.98 | $693,432 | $177,450 |
| 2023 | 576 | 1,375 | 78 | 1.06 | $567,086 | $155,496 |
| 2022 | 619 | 1,393 | 77 | 1.02 | $540,880 | $152,656 |
| 2021 | 611 | 1,398 | 78 | 1.06 | $533,061 | $155,986 |
| 2020 | 442 | 1,022 | 77 | 1.13 | $357,070 | $95,764 |
| 2019 | 713 | 1,602 | 76 | 1.11 | $562,050 | $144,786 |
| 2018 | 672 | 1,502 | 77 | 1.12 | $513,326 | $129,580 |
| 2017 | 674 | 1,620 | 76 | 1.08 | $543,711 | $142,686 |
| 2016 | 541 | 1,442 | 76 | 1.19 | $511,768 | $136,397 |
| 2015 | 511 | 1,266 | 76 | 1.10 | $438,079 | $133,494 |
| 2014 | 393 | 830 | 76 | 1.04 | $286,151 | $84,205 |
| 2013 | 355 | 795 | 77 | 1.20 | $279,840 | $83,713 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| New patient visit (45+ min) | 290 | $41,647 | $144 |
| Return visit (30+ min) | 251 | $37,623 | $115 |
| Diagnostic exam of voice box using a flexible endoscope | 235 | $37,019 | $134 |
| Removal of impacted ear wax | 207 | $9,725 | $41 |
| Short return visit (20+ min) | 59 | $5,381 | $75 |
| Long return visit (40+ min) | 30 | $5,231 | $174 |
| Simple control of nose bleed | 13 | $2,122 | $163 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 15 | $764 | $51 |
2022: 10 services
| Return visit (30+ min) | 285 | $39,259 | $113 |
| Diagnostic exam of voice box using a flexible endoscope | 226 | $34,771 | $133 |
| New patient visit (45+ min) | 230 | $33,387 | $145 |
| Short return visit (20+ min) | 101 | $10,409 | $79 |
| Removal of impacted ear wax | 211 | $9,420 | $40 |
| New patient visit (30+ min) | 48 | $4,345 | $91 |
| Long return visit (40+ min) | 20 | $3,233 | $162 |
| Simple control of nose bleed | 15 | $3,077 | $154 |
| Repositioning exercises of head for treatment of dizziness, each day | 17 | $798 | $40 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 12 | $561 | $47 |
2021: 10 services
| New patient visit (45+ min) | 270 | $41,075 | $152 |
| Return visit (30+ min) | 223 | $34,055 | $116 |
| Diagnostic exam of voice box using a flexible endoscope | 212 | $34,019 | $131 |
| Short return visit (20+ min) | 112 | $11,650 | $79 |
| Removal of impacted ear wax | 193 | $9,195 | $42 |
| New patient visit (30+ min) | 72 | $6,468 | $90 |
| Simple control of nose bleed | 21 | $4,515 | $167 |
| Long return visit (40+ min) | 15 | $2,648 | $177 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 17 | $812 | $48 |
| Repositioning exercises of head for treatment of dizziness, each day | 12 | $439 | $37 |
2020: 8 services
| Diagnostic exam of voice box using a flexible endoscope | 153 | $22,378 | $122 |
| New patient visit (30+ min) | 193 | $16,997 | $88 |
| Short return visit (20+ min) | 138 | $13,524 | $69 |
| Return visit (30+ min) | 126 | $13,165 | $94 |
| Removal of impacted ear wax | 139 | $6,229 | $41 |
| New patient visit (45+ min) | 31 | $4,179 | $135 |
| Simple control of nose bleed | 16 | $2,899 | $138 |
| New patient visit (15+ min) | 11 | $606 | $55 |
2019: 11 services
| Diagnostic exam of voice box using a flexible endoscope | 288 | $39,511 | $112 |
| New patient visit (30+ min) | 302 | $27,529 | $91 |
| Short return visit (20+ min) | 214 | $18,960 | $66 |
| Return visit (30+ min) | 181 | $18,231 | $93 |
| Removal of impacted ear wax | 186 | $8,078 | $40 |
| New patient visit (45+ min) | 37 | $4,883 | $132 |
| Simple control of nose bleed | 13 | $1,879 | $134 |
| New patient visit (15+ min) | 24 | $1,515 | $63 |
| Repositioning exercises of head for treatment of dizziness, each day | 15 | $623 | $39 |
| Exam of ear using a microscope | 15 | $571 | $27 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 12 | $544 | $45 |
2018: 11 services
| Diagnostic exam of voice box using a flexible endoscope | 218 | $28,173 | $105 |
| New patient visit (30+ min) | 320 | $28,166 | $88 |
| Short return visit (20+ min) | 210 | $18,260 | $64 |
| Return visit (30+ min) | 171 | $17,092 | $89 |
| Removal of impacted ear wax | 164 | $7,351 | $41 |
| New patient visit (45+ min) | 31 | $3,960 | $128 |
| Simple control of nose bleed | 22 | $3,618 | $129 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 22 | $1,082 | $49 |
| Repositioning exercises of head for treatment of dizziness, each day | 21 | $917 | $40 |
| Exam of ear using a microscope | 23 | $803 | $30 |
| New patient visit (15+ min) | 11 | $765 | $70 |
2017: 10 services
| New patient visit (30+ min) | 362 | $32,245 | $89 |
| Diagnostic exam of voice box using a flexible endoscope | 223 | $31,476 | $108 |
| Short return visit (20+ min) | 215 | $21,818 | $64 |
| Return visit (30+ min) | 164 | $16,125 | $87 |
| Removal of impacted ear wax | 167 | $7,820 | $42 |
| Simple control of nose bleed | 26 | $2,990 | $83 |
| New patient visit (45+ min) | 19 | $2,637 | $139 |
| Complex control of nose bleed | 11 | $2,477 | $206 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 17 | $839 | $49 |
| Repositioning exercises of head for treatment of dizziness, each day | 18 | $734 | $39 |
2016: 14 services
| New patient visit (30+ min) | 239 | $21,929 | $92 |
| Short return visit (20+ min) | 217 | $20,241 | $63 |
| Diagnostic exam of voice box using a flexible endoscope | 132 | $17,442 | $110 |
| Return visit (30+ min) | 168 | $16,538 | $90 |
| Diagnostic exam of nasal passages using an endoscope | 59 | $13,756 | $208 |
| Removal of impacted ear wax | 156 | $7,475 | $42 |
| New patient visit (45+ min) | 25 | $3,568 | $143 |
| Complex control of nose bleed | 14 | $3,260 | $217 |
| Simple control of nose bleed | 29 | $2,859 | $89 |
| Fine needle aspiration biopsy, first growth | 15 | $2,067 | $115 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,071 | $89 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 18 | $912 | $51 |
| Exam of ear using a microscope | 14 | $577 | $27 |
| Repositioning exercises of head for treatment of dizziness, each day | 14 | $551 | $39 |
2015: 9 services
| New patient visit (30+ min) | 235 | $22,996 | $98 |
| Short return visit (20+ min) | 200 | $19,876 | $64 |
| Diagnostic exam of nasal passages using an endoscope | 78 | $19,233 | $209 |
| Return visit (30+ min) | 139 | $15,745 | $102 |
| Diagnostic exam of voice box using a flexible endoscope | 113 | $14,356 | $115 |
| Removal of impacted ear wax | 139 | $7,206 | $48 |
| New patient visit (45+ min) | 25 | $3,717 | $149 |
| Simple control of nose bleed | 22 | $2,334 | $90 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 11 | $583 | $53 |
2014: 6 services
| Short return visit (20+ min) | 222 | $21,780 | $64 |
| New patient visit (30+ min) | 174 | $15,655 | $90 |
| Diagnostic exam of nasal passages using an endoscope | 47 | $12,749 | $193 |
| Diagnostic exam of voice box using a flexible endoscope | 83 | $10,689 | $110 |
| Return visit (30+ min) | 55 | $5,118 | $93 |
| Simple control of nose bleed | 13 | $1,034 | $80 |
2013: 6 services
| Short return visit (20+ min) | 182 | $18,405 | $62 |
| New patient visit (30+ min) | 165 | $15,653 | $95 |
| Diagnostic exam of nasal passages using an endoscope | 39 | $12,294 | $181 |
| Diagnostic exam of voice box using a flexible endoscope | 82 | $10,520 | $111 |
| Return visit (30+ min) | 51 | $4,776 | $90 |
| New patient visit (45+ min) | 14 | $2,050 | $146 |
Drugs they prescribed that Part D paid
$25,156
Pharmacies billed $25,156 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,056 generic and fewer than 11 brand-name prescriptions · $25,156 in drug cost · 89 antibiotic prescriptions to 70 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Azelastine | 295 | $9,700 | $33 |
| Fluticasone Propionate | 184 | $3,270 | $18 |
| Ipratropium | 109 | $3,022 | $28 |
| Clotrimazole | 31 | $854 | $28 |
| Famotidine | 42 | $452 | $11 |
See all 16 drugs
| Azelastine | 295 | $9,700 | $33 |
| Fluticasone Propionate | 184 | $3,270 | $18 |
| Ipratropium | 109 | $3,022 | $28 |
| Clotrimazole | 31 | $854 | $28 |
| Famotidine | 42 | $452 | $11 |
| Ofloxacin | 14 | $450 | $32 |
| Clotrimazole-Betamethasone | 40 | $409 | $10 |
| Omeprazole | 43 | $396 | $9 |
| Fluocinolone Acetonide Oil | 16 | $340 | $21 |
| Gabapentin | 16 | $223 | $14 |
| Mupirocin | 35 | $218 | $6 |
| Amoxicillin-Clavulanate Potass | 12 | $138 | $11 |
| Cephalexin | 20 | $135 | $7 |
| Prednisone | 43 | $108 | $3 |
| Meclizine | 12 | $77 | $6 |
| Amoxicillin | 11 | $30 | $3 |
Year by year
| 2024 | 1,065 | 354 | None | None | $25,156 |
| 2023 | 950 | 324 | None | None | $28,626 |
| 2022 | 857 | 327 | None | None | $27,443 |
| 2021 | 947 | 328 | None | 2% | $30,396 |
| 2020 | 809 | 267 | None | None | $24,732 |
| 2019 | 1,062 | 363 | None | 2% | $34,566 |
| 2018 | 1,010 | 329 | None | 4% | $27,916 |
| 2017 | 1,018 | 341 | None | 6% | $31,573 |
| 2016 | 870 | 285 | None | 16% | $35,760 |
| 2015 | 777 | 257 | None | 13% | $31,980 |
| 2014 | 578 | 197 | None | 12% | $24,351 |
| 2013 | 490 | 148 | None | 15% | $26,498 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Azelastine | 285 | $9,678 | $34 |
| Fluticasone Propionate | 150 | $2,973 | $20 |
| Ipratropium | 113 | $2,781 | $25 |
| Fluocinolone Acetonide Oil | 18 | $1,433 | $80 |
| Budesonide | 11 | $1,166 | $106 |
| Clotrimazole | 22 | $956 | $43 |
| Ofloxacin | 13 | $914 | $70 |
| Famotidine | 46 | $579 | $13 |
| Omeprazole | 38 | $560 | $15 |
| Clotrimazole-Betamethasone | 35 | $480 | $14 |
| Mupirocin | 24 | $194 | $8 |
| Prednisone | 37 | $151 | $4 |
| Cephalexin | 12 | $85 | $7 |
2022: 15 drugs
| Azelastine | 243 | $11,655 | $48 |
| Ipratropium | 70 | $2,988 | $43 |
| Fluticasone Propionate | 150 | $2,624 | $17 |
| Ofloxacin | 15 | $1,502 | $100 |
| Clotrimazole | 24 | $1,040 | $43 |
| Fluocinolone Acetonide Oil | 14 | $779 | $56 |
| Omeprazole | 70 | $607 | $9 |
| Gentamicin Sulfate | 14 | $428 | $31 |
| Famotidine | 29 | $402 | $14 |
| Mupirocin | 40 | $378 | $9 |
| Cephalexin | 19 | $167 | $9 |
| Clotrimazole-Betamethasone | 14 | $116 | $8 |
| Prednisone | 19 | $91 | $5 |
| Amoxicillin | 19 | $82 | $4 |
| Hydrocortisone | 11 | $43 | $4 |
2021: 15 drugs
| Azelastine | 257 | $10,815 | $42 |
| Ipratropium | 63 | $3,589 | $57 |
| Fluticasone Propionate | 153 | $2,881 | $19 |
| Ofloxacin | 32 | $1,639 | $51 |
| Clotrimazole | 31 | $1,485 | $48 |
| Fluocinolone Acetonide Oil | 14 | $943 | $67 |
| Omeprazole | 68 | $710 | $10 |
| Triamcinolone Acetonide | 25 | $649 | $26 |
| Gentamicin Sulfate | 21 | $406 | $19 |
| Mupirocin | 33 | $293 | $9 |
| Cephalexin | 21 | $180 | $9 |
| Clotrimazole-Betamethasone | 15 | $165 | $11 |
| Prednisone | 27 | $122 | $5 |
| Hydrocortisone | 11 | $73 | $7 |
| Amoxicillin | 17 | $56 | $3 |
2020: 16 drugs
| Azelastine | 187 | $8,287 | $44 |
| Ipratropium | 97 | $5,261 | $54 |
| Fluticasone Propionate | 136 | $2,555 | $19 |
| Ofloxacin | 21 | $1,199 | $57 |
| Fluocinolone Acetonide Oil | 12 | $744 | $62 |
| Clotrimazole | 13 | $727 | $56 |
| Omeprazole | 62 | $532 | $9 |
| Gentamicin Sulfate | 18 | $398 | $22 |
| Cefdinir | 11 | $367 | $33 |
| Triamcinolone Acetonide | 14 | $342 | $24 |
| Famotidine | 30 | $320 | $11 |
| Mupirocin | 18 | $274 | $15 |
| Cephalexin | 14 | $153 | $11 |
| Ciprofloxacin | 15 | $110 | $7 |
| Prednisone | 19 | $92 | $5 |
| Amoxicillin | 14 | $50 | $4 |
2019: 19 drugs
| Azelastine | 243 | $11,148 | $46 |
| Ipratropium | 81 | $3,374 | $42 |
| Fluticasone Propionate | 169 | $2,774 | $16 |
| Ofloxacin | 30 | $2,548 | $85 |
| Clotrimazole | 24 | $1,203 | $50 |
| Omeprazole | 98 | $1,084 | $11 |
| Fluocinolone Acetonide Oil | 13 | $987 | $76 |
| Ranitidine | 30 | $606 | $20 |
| Gentamicin Sulfate | 18 | $563 | $31 |
| Cefdinir | 13 | $544 | $42 |
| Mupirocin | 49 | $445 | $9 |
| Doxycycline Hyclate | 18 | $387 | $22 |
| Cephalexin | 27 | $323 | $12 |
| Amoxicillin-Clavulanate Potass | 17 | $262 | $15 |
| Ciprofloxacin | 16 | $236 | $15 |
| Clotrimazole-Betamethasone | 16 | $217 | $14 |
| Famotidine | 17 | $211 | $12 |
| Amoxicillin | 22 | $138 | $6 |
| Prednisone | 24 | $111 | $5 |
2018: 18 drugs
| Azelastine | 225 | $10,102 | $45 |
| Ipratropium | 59 | $2,407 | $41 |
| Fluticasone Propionate | 147 | $2,400 | $16 |
| Gentamicin Sulfate | 33 | $1,798 | $54 |
| Omeprazole | 103 | $1,101 | $11 |
| Ranitidine | 47 | $749 | $16 |
| Clotrimazole | 15 | $734 | $49 |
| Ciprofloxacin | 41 | $573 | $14 |
| Doxycycline Hyclate | 24 | $486 | $20 |
| Clotrimazole-Betamethasone | 25 | $413 | $17 |
| Mupirocin | 41 | $390 | $10 |
| Amoxicillin-Clavulanate Potass | 19 | $222 | $12 |
| Prednisone | 32 | $189 | $6 |
| Cephalexin | 14 | $146 | $10 |
| Ondansetron | 18 | $124 | $7 |
| Meclizine | 13 | $99 | $8 |
| Amoxicillin | 22 | $97 | $4 |
| Famotidine | 13 | $84 | $6 |
2017: 18 drugs
| Azelastine | 244 | $12,148 | $50 |
| Fluticasone Propionate | 184 | $2,894 | $16 |
| Fluocinolone Acetonide Oil | 13 | $1,812 | $139 |
| Gentamicin Sulfate | 37 | $1,482 | $40 |
| Clotrimazole | 17 | $870 | $51 |
| Ipratropium | 21 | $634 | $30 |
| Omeprazole | 82 | $531 | $6 |
| Clotrimazole-Betamethasone | 21 | $447 | $21 |
| Ciprofloxacin | 48 | $446 | $9 |
| Ranitidine | 44 | $426 | $10 |
| Mupirocin | 45 | $400 | $9 |
| Amoxicillin-Clavulanate Potass | 18 | $282 | $16 |
| Cephalexin | 19 | $204 | $11 |
| Pantoprazole | 16 | $190 | $12 |
| Prednisone | 34 | $165 | $5 |
| Amoxicillin | 23 | $88 | $4 |
| Famotidine | 12 | $76 | $6 |
| Sulfamethoxazole-Trimethoprim | 13 | $68 | $5 |
2016: 20 drugs
| Azelastine | 165 | $7,123 | $43 |
| Ciprodex | 24 | $5,212 | $217 |
| Fluticasone Propionate | 168 | $2,424 | $14 |
| Gentamicin Sulfate | 42 | $1,911 | $45 |
| Fluocinolone Acetonide Oil | 11 | $1,587 | $144 |
| Clotrimazole | 15 | $1,007 | $67 |
| Omeprazole | 82 | $950 | $12 |
| Clotrimazole-Betamethasone | 24 | $816 | $34 |
| Mupirocin | 45 | $614 | $14 |
| Ciprofloxacin | 24 | $279 | $12 |
| Ranitidine | 33 | $264 | $8 |
| Ipratropium | 12 | $249 | $21 |
| Cephalexin | 23 | $200 | $9 |
| Amoxicillin-Clavulanate Potass | 12 | $199 | $17 |
| Methylprednisolone | 12 | $197 | $16 |
| Famotidine | 14 | $144 | $10 |
| Sulfamethoxazole-Trimethoprim | 13 | $104 | $8 |
| Amoxicillin | 16 | $101 | $6 |
| Ibuprofen | 16 | $90 | $6 |
| Prednisone | 18 | $90 | $5 |
2015: 17 drugs
| Ciprodex | 32 | $5,961 | $186 |
| Azelastine | 96 | $5,021 | $52 |
| Fluocinolone Acetonide Oil | 19 | $3,025 | $159 |
| Fluticasone Propionate | 155 | $1,680 | $11 |
| Clotrimazole | 16 | $1,150 | $72 |
| Ofloxacin | 12 | $1,116 | $93 |
| Ipratropium | 40 | $1,004 | $25 |
| Omeprazole | 71 | $708 | $10 |
| Mupirocin | 47 | $445 | $9 |
| Ibuprofen | 38 | $392 | $10 |
| Gentamicin Sulfate | 15 | $375 | $25 |
| Amoxicillin-Clavulanate Potass | 12 | $263 | $22 |
| Ciprofloxacin | 21 | $237 | $11 |
| Cephalexin | 27 | $206 | $8 |
| Prednisone | 27 | $122 | $5 |
| Sulfamethoxazole-Trimethoprim | 13 | $88 | $7 |
| Ranitidine | 12 | $66 | $6 |
2014: 15 drugs
| Fluocinolone Acetonide Oil | 23 | $4,485 | $195 |
| Patanase | 17 | $3,450 | $203 |
| Ciprodex | 18 | $2,869 | $159 |
| Azelastine | 33 | $2,082 | $63 |
| Fluticasone Propionate | 91 | $1,566 | $17 |
| Triamcinolone Acetonide | 14 | $1,410 | $101 |
| Clotrimazole | 17 | $1,232 | $72 |
| Omeprazole | 108 | $1,055 | $10 |
| Ofloxacin | 16 | $506 | $32 |
| Ipratropium | 25 | $438 | $18 |
| Mupirocin | 37 | $376 | $10 |
| Ibuprofen | 17 | $183 | $11 |
| Ciprofloxacin | 21 | $164 | $8 |
| Sulfamethoxazole-Trimethoprim | 13 | $145 | $11 |
| Prednisone | 23 | $118 | $5 |
2013: 12 drugs
| Patanase | 21 | $3,496 | $166 |
| Ciprodex | 20 | $2,979 | $149 |
| Azelastine | 32 | $2,552 | $80 |
| Fluticasone Propionate | 91 | $2,371 | $26 |
| Fluocinolone Acetonide Oil | 22 | $1,563 | $71 |
| Omeprazole | 95 | $1,257 | $13 |
| Clotrimazole | 14 | $962 | $69 |
| Mupirocin | 27 | $336 | $12 |
| Ipratropium | 18 | $308 | $17 |
| Ciprofloxacin | 13 | $121 | $9 |
| Sulfamethoxazole-Trimethoprim | 11 | $79 | $7 |
| Prednisone | 17 | $72 | $4 |
Money from drug and device companies
$15 in 2021
| 2021 | 1 | 1 | None | $15 |
| 2020 | 1 | 2 | None | $44 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Exalt | $15 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2021-03-31 | Exalt | $15 |
See earlier years (2020)
2020: $44
| Covidien LP | Prodigi | $44 | 2 payments
|
Professional record
- NPI
- 1306926985
- Licence
- CA A62150California A62150: Current · expires 2028-09-30
- Trained
- Northwestern University Feinberg Medical School, 1995
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-10-17
- NPI last updated
- 2011-12-02
This is when the NPI record was last certified, not a medical board exam.